ReviewFrontiers in endocrinology2021
Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.
Erratum issuedOpen access · goldAbstract readReviewConsensus Statement
In one paragraph
Review in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.
- X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.The Journal of clinical endocrinology and metabolism · 2025Guideline
- X-linked hypophosphatemia and tumor-induced osteomalacia: a narrative review and expert opinion on the diagnostic and therapeutic challenges in the era of burosumab.Orphanet journal of rare diseases · 2025Review
- Hypophosphatemia in the Diagnosis and Management of Primary Hyperparathyroidism.Journal of clinical medicine · 2025Article
- Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan.Journal of endocrinological investigation · 2025Article
- Approach to a Child with Hypophosphatemia.Biomolecules · 2025Review
- Real-world effectiveness of burosumab vs oral phosphate and active vitamin D in adults with X-linked hypophosphatemia.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025Observational
- Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience.The Journal of clinical endocrinology and metabolism · 2025Article
- Short stature in pre-pubertal children with X-linked hypophosphatemia.Endocrine connections · 2025Article
- [Clinical polymorphism of primary hyperparathyroidism in children].Problemy endokrinologii · 2025Observational
- Calcium isotope ratio in patients with monogenic bone diseases: a prospective, cross-sectional, single-center pilot study.JBMR plus · 2025Article
- Characterization of adult patients with X-linked hypophosphatemia at a specialized center in Buenos Aires, Argentina.Archives of endocrinology and metabolism · 2025Observational
- Disease burden and health-related quality of life among children with X-linked hypophosphataemia in China: a national cross-sectional survey.BMJ paediatrics open · 2025Article
- Areas of uncertainty on the diagnosis, treatment, and follow-up of hypophosphatemia in adults: an Italian Delphi consensus.Journal of endocrinological investigation · 2025Article
- Biochemical evaluation of X-linked hypophosphatemia and tumor-induced osteomalacia: insights into diagnosis and management.Frontiers in endocrinology · 2025Review
- Real-World Clinical and Healthcare Resource Burden Among Burosumab-Naïve Patients With Familial Hypophosphatemia.Journal of the Endocrine Society · 2024Article
- Lessons learned from the real-world diagnosis and management of hereditary hypophosphatemic rickets.Bone reports · 2024Article
- Phosphate Homeostasis and Disorders of Phosphate Metabolism.Current pediatric reviews · 2024Review
- Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH).International journal of oral science · 2023Article
- The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data.Orphanet journal of rare diseases · 2023Article
- Co-occurrence of Spondyloepiphyseal Dysplasia and X-Linked Hypophosphatemia in a Three-Generation Chinese Family.Calcified tissue international · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
19 authors at 9 institutions in 1 country.
Michaël R LaurentCentre for Metabolic Bone Diseases, University Hospitals Leuven, Leuven, Belgium.
Jean De SchepperDivision of Pediatric Endocrinology, KidZ Health Castle, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dominique TrouetDepartment of Pediatric Nephrology, Antwerp University Hospital, Antwerp, Belgium.
Nathalie GodefroidPediatric Nephrology, Cliniques Universitaires St. Luc (UCL), Brussels, Belgium.
Emese BorosPaediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
Claudine HeinrichsPaediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
Bert BravenboerDepartment of Endocrinology, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Brigitte VelkeniersDepartment of Endocrinology, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Johan LammensDepartment of Orthopaedic Surgery and Department of Development and Regeneration, Prometheus LRD Division of Skeletal Tissue Engineering, KU Leuven - University Hospitals Leuven, Leuven, Belgium.
Pol HarvengtXLH Belgium, Belgian X-Linked Hypophosphatemic Rickets (XLH) Patient Association, Waterloo, Belgium.
Etienne CavalierDepartment of Clinical Chemistry, University Hospital Center of Liège, University of Liège, Liège, Belgium.
Jean-François KauxPhysical Medicine, Rehabilitation and Sports Traumatology, University and University Hospital of Liège, Liège, Belgium.
Jacques LombetDivision of Nephrology, Department of Pediatrics, University Hospital Center of Liège, Liège, Belgium.
Kathleen De WaeleDepartment of Pediatric Endocrinology, University Hospital Ghent, Ghent, Belgium.
Charlotte VerrokenUnit for Osteoporosis and Metabolic Bone Diseases, Department of Endocrinology and Metabolism, Ghent University Hospital, Ghent, Belgium.
Koenraad van HoeckDepartment of Pediatric Nephrology, Antwerp University Hospital, Antwerp, Belgium.
Geert R MortierDepartment of Medical Genetics, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium.
Elena LevtchenkoDepartment of Pediatrics/Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium.
Johan Vande WalleDepartment of Pediatric Nephrology, University Hospital Ghent, Ghent, Belgium.
Ghent University Hospital · BEKU Leuven · BEVrije Universiteit Brussel · BEUniversity of Antwerp · BEAntwerp University Hospital · BECliniques Universitaires Saint-Luc · BEQueen Fabiola Children's University Hospital · BEUniversité Libre de Bruxelles · BEUniversity of Liège · BE
Funding
No grant is acknowledged in the PubMed record.
Abstract
X-linked hypophosphatemia (XLH) is the most common genetic form of hypophosphatemic rickets and osteomalacia. In this disease, mutations in the
Indexed as
MutationAlkaline PhosphataseAntibodies, Monoclonal, HumanizedBelgiumFamilial Hypophosphatemic RicketsFibroblast Growth Factor-23HumansHypophosphatemiaInterdisciplinary CommunicationOsteomalaciaPHEX Phosphate Regulating Neutral EndopeptidaseSeverity of Illness IndexSocieties, MedicalTreatment OutcomeVitamin DAlkaline PhosphataseAntibodies, Monoclonal, HumanizedburosumabFGF23 protein, humanFibroblast Growth Factor-23PHEX Phosphate Regulating Neutral EndopeptidasePHEX protein, humanVitamin Dburosumabfibroblast growth factor 23 (FGF23)osteomalaciaricketsvitamin DX-linked hypophosphatemia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.